Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nader Fotouhi

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|October 27, 2006
Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activityXin-Jie Chu, Wanda DePinto, David Bartkovitz, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2024
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosisLourdes Encinas, Si-Yang Li, Joaquin Rullas-Trincado, et al.
Journal of Medicinal Chemistry|December 12, 2025
Unique Interactions of Novel Rufomycin "Click Chemistry" Analogs with <i>Mtb</i> ClpC1 and ImplicationsKiira Ratia, Shengnan Jin, Celerino Abad-Zapatero, et al.
Cancer Research|February 19, 2008
A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavageSherif Daouti, Wen-hui Li, Hong Qian, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitorsPaul Gillespie, Sherrie Pietranico-Cole, Michael Myers, et al.
Journal of Medicinal Chemistry|January 5, 2002
Development of a virtual screening method for identification of "frequent hitters" in compound librariesOlivier Roche, Petra Schneider, Jochen Zuegge, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.
Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.
Science Advances|May 23, 2020
Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerizationJaspreet Banga, Dinesh Srinivasan, Chia-Chi Sun, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|October 27, 2006
Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activityXin-Jie Chu, Wanda DePinto, David Bartkovitz, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2024
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosisLourdes Encinas, Si-Yang Li, Joaquin Rullas-Trincado, et al.
Journal of Medicinal Chemistry|December 12, 2025
Unique Interactions of Novel Rufomycin "Click Chemistry" Analogs with <i>Mtb</i> ClpC1 and ImplicationsKiira Ratia, Shengnan Jin, Celerino Abad-Zapatero, et al.
Cancer Research|February 19, 2008
A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavageSherif Daouti, Wen-hui Li, Hong Qian, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitorsPaul Gillespie, Sherrie Pietranico-Cole, Michael Myers, et al.
Journal of Medicinal Chemistry|January 5, 2002
Development of a virtual screening method for identification of "frequent hitters" in compound librariesOlivier Roche, Petra Schneider, Jochen Zuegge, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.
Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.
Science Advances|May 23, 2020
Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerizationJaspreet Banga, Dinesh Srinivasan, Chia-Chi Sun, et al.
Pageof 4